A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
A study to assess the effects of Sativex treatment on spasticity in a population of children and adolescents aged from 8 to 18 years with cerebral palsy or traumatic central nervous system injury. Efficacy (ability to improve symptoms), safety and tolerability will be monitored.
Epistemonikos ID: 74a5fd4c2f7d745abbb2e7d8d2d742f5ada25ffe
First added on: Apr 23, 2019